To date the incident sample has been received for evaluation.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Additional devices: suprarenal aorta uni-iliac: model: a34-34/c100-020, lot number: w11-4432-024, lot release date: 09/28/2011, lot expiration date: 08/31/2012 ; suprarenal aorta uni-iliac: lot number: w11-2660r-005, lot release date: 04/30/2012, lot expiration date: 04/30/2014 ; infrarenal aorto uni-iliac: lot number: w11-4711-007, lot release date: 10/13/2011, lot expiration date: 8/31/2012.
|
It was reported the patient had an initial procedure on (b)(6) 2012 with a bifurcated device, a suprarenal and an infrarenal aortic extension.On (b)(6) 2012 patient admitted emergently for suspected 1b endoleak.The endoleak could not be confirmed and the physician elected to implant a new suprarenal aortic extension, post procedure the physician confirmed no leaks were present.A follow-up in (b)(6) 2014 showed an aneurysm sac increase with possible type ii endoleak.The patient was referred to another physician for treatment.On (b)(6) 2015 patient admitted to the emergency room with emergent-rupture.The implant appeared to be disconnected and aortic extension was protruding through the aorta, it was also noted that the tissue surrounding the renals was degraded.The physician elected to explant and attempt an open repair.The procedure was completed and the patient was transferred to the icu post op.However, the patient expired in post op.
|